New drug fezolinetant tested for menopause hot flashes in canadian women
NCT ID NCT07602530
First seen May 22, 2026 · Last updated May 22, 2026
Summary
This study follows Canadian women in menopause who are prescribed fezolinetant by their own doctor for hot flashes and night sweats. Researchers will track how well the drug improves these symptoms after 12 weeks, as well as sleep and overall well-being. The study is observational, meaning treatment decisions are made by the doctor, not the study sponsor.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HOT FLASHES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Site CA15001
RECRUITINGPrince Albert, Canada
-
Site CA15002
RECRUITINGMontreal, Canada
Conditions
Explore the condition pages connected to this study.